Scientia Future Oncology, 18(7), 781-791. FUTURE MEDICINE LTD Riely, G J, Ahn, M-J, Felip, E, Ramalingam, S S, Smit, E F, Tsao, A S, Alcasid, A, Usari, T, Wissel, P S, Wilner, K D & Johnson, B E 2022, ' Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer : Phase II PHAROS study design ', Future Oncology, vol. 18, no. 7, pp. 781-791 . https://doi.org/10.2217/fon-2021-1250